Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | DLX | TRIP |
|---|---|---|
| Price | $22.42 | $8.68 |
| Change today | ▲ 0.22% | ▲ 0.58% |
| Market cap | $1.03B | $1.02B |
| Return, 3 months | -6.1% | -34.9% |
| Return, year to date | +4.1% | -40.4% |
| Return, 1 year | +24.3% | -44.1% |
| P/E (TTM) | 10.3 | 289.3 |
| P/B | 1.5 | 1.5 |
| P/E percentile vs own 5y | 2nd | 89th |
| Dividend yield | 5.35% | – |
| Revenue growth (YoY, latest qtr) | -4.2% | -7.2% |
| Net profit growth (YoY) | -14.3% | -37.8% |
| Gross margin | 52.5% | 92.1% |
| Operating margin | 12.5% | 4.5% |
| Net margin | 4.8% | 0.3% |
| Return on equity | 14.9% | 0.8% |
| Analyst target vs. price | +38.3% | +53.8% |
| Analyst buy share | 100% | 36% |
| RSI (14) | 35 | 42 |
| 30-day volatility | 25.2% | 38.0% |
| Max drawdown, 1 year | -29.4% | -53.1% |
| Trend read | Strong downtrend | Leaning bearish |
| Analyst consensus | Buy | Hold |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
